Peptides and PEDs on TikTok: separating hype from human data

What did @kinggbraddfitness actually say?

The creator is a 22-year-old who admits to taking testosterone while dismissing peptides as a trend. His core argument: peptides are "like the new hype thing" with unknown long-term safety, testosterone is the most researched option, and any PED will amplify whatever you're genetically prone to. He says he does not recommend anyone take any of this.

He's not selling anything here, which is worth noting. He's a self-described testosterone user giving opinions on his own experience, not a clinician making therapeutic claims. His honesty about his own baldness and the genetics behind it is refreshing compared to the usual TikTok fitness content that glosses over side effects entirely.

Does the science back this up?

On the genetics-amplification point, he's largely correct. On peptides being "brand new" with unknown safety, he's partially right but overstates the novelty. Some peptides have been studied for decades.

The claim that exogenous testosterone accelerates androgenetic alopecia in genetically susceptible individuals is well-supported. Testosterone converts to dihydrotestosterone (DHT) via the enzyme 5-alpha reductase, and DHT is the primary driver of male pattern baldness in those with androgen-sensitive hair follicles. A review by Blumeyer et al. (2011, Journal of the German Society of Dermatology) confirmed that androgen sensitivity, not testosterone levels alone, determines follicular response. His framing, that predisposed individuals lose hair faster on testosterone, is accurate.

On acne, the evidence is similarly solid. Elevated androgens increase sebum production and follicular keratinocyte activity. A study by Capitanio et al. (2009, Journal of the European Academy of Dermatology and Venereology) found acne prevalence significantly elevated among anabolic steroid users, particularly those with prior acne history.

On peptides being "brand new," that's not quite right. BPC-157 has animal data going back to the 1990s. GHK-Cu has been studied since the 1970s. What's true is that robust human clinical trials are sparse, and long-term safety data in healthy humans is genuinely limited.

What did they get wrong (or right)?

He gets the genetics-amplification framing mostly right, but his characterization of peptides as uniformly new and untested is too broad. He's right to be cautious, but wrong to lump all peptides together.

His claim that "test is best" because it's "the most researched" has a real kernel of truth but ignores context. Testosterone replacement therapy in hypogonadal men has extensive clinical backing. Testosterone use in a healthy 22-year-old for performance purposes is a different pharmacological situation entirely, with a separate risk profile that includes suppression of endogenous hormone production, cardiovascular strain, and fertility effects. He doesn't mention any of that.

He also says you "won't know" side effects until you take something, which is partially true but undersells what bloodwork, genetic testing, and clinical supervision can actually tell you in advance. That framing encourages a trial-and-error approach that a supervised medical context would significantly improve on.

Credit where it's due: he explicitly and repeatedly says he does not recommend anyone take anything. That's not the typical influencer play.

What should you actually know?

If you're considering any exogenous hormone or peptide, the genetic amplification point this creator makes is one of the more practically useful things you'll hear on fitness TikTok. It's not scare-mongering, it's physiology.

Peptides vary enormously by mechanism, evidence base, and regulatory status. BPC-157 has shown tissue repair effects in animal models (Chang et al., 2011, Journal of Physiology) but has no completed Phase II or III human trials for most claimed uses. MK-677 is not a peptide but a ghrelin receptor agonist, and it carries documented risks including insulin resistance and water retention (Murphy et al., 1998, Journal of Clinical Endocrinology and Metabolism). Grouping all peptides together the way this creator does, and the way most TikTok content does, flattens meaningful differences.

Testosterone use without medical oversight in a young adult carries real risks: suppression of the hypothalamic-pituitary-gonadal axis, potential long-term fertility effects, and cardiovascular changes including left ventricular hypertrophy noted in long-term users (Baggish et al., 2017, Circulation: Heart Failure). None of this makes it categorically off-limits, but it does make the "do your research" advice insufficient without specifying what that research should include and who should be interpreting your labs.

• DHT-driven hair loss accelerates with exogenous androgen use in genetically susceptible individuals.
• Acne history is a meaningful predictor of androgen-related skin side effects.
• Peptide safety data in humans is genuinely thin for most compounds, especially long-term.
• "Test is best" reflects real research depth, but not necessarily safety in non-hypogonadal young men.